Loading...
XLONTATE
Market cap3.66bUSD
Dec 23, Last price  
661.00GBP
1D
-1.78%
1Q
-0.60%
Jan 2017
-19.92%
Name

Tate & Lyle PLC

Chart & Performance

D1W1MN
XLON:TATE chart
P/E
1,553.68
P/S
177.35
EPS
0.43
Div Yield, %
0.03%
Shrs. gr., 5y
0.09%
Rev. gr., 5y
-9.78%
Revenues
1.65b
-5.94%
3,339,000,0003,465,000,0003,225,000,0002,867,000,0003,553,000,0002,533,000,0002,720,000,0003,088,000,0003,256,000,0003,147,000,0002,356,000,0002,355,000,0002,753,000,0002,710,000,0002,755,000,0002,882,000,0001,211,000,0001,375,000,0001,751,000,0001,647,000,000
Net income
188m
-1.05%
146,000,000-30,000,000214,000,000194,000,00065,000,00015,000,000163,000,000305,000,000277,000,000273,000,00030,000,000121,000,000256,000,000265,000,000181,000,000245,000,000253,000,000236,000,000190,000,000188,000,000
CFO
208m
+76.27%
191,000,00087,000,000227,000,000162,000,000501,000,000522,000,000122,000,000231,000,000251,000,000384,000,000179,000,000188,000,000298,000,000286,000,000330,000,000425,000,000374,000,000137,000,000118,000,000208,000,000
Dividend
Jun 20, 202412.9 GBP/sh
Earnings
May 21, 2025

Profile

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company engages in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
IPO date
Dec 09, 1938
Employees
3,604
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
1,647,000
-5.94%
1,751,000
27.35%
1,375,000
13.54%
Cost of revenue
1,196,000
1,301,000
1,077,000
Unusual Expense (Income)
NOPBT
451,000
450,000
298,000
NOPBT Margin
27.38%
25.70%
21.67%
Operating Taxes
47,000
25,000
16,000
Tax Rate
10.42%
5.56%
5.37%
NOPAT
404,000
425,000
282,000
Net income
188,000
-1.05%
190,000
-19.49%
236,000
-6.72%
Dividends
(76,000)
(570,000)
(144,000)
Dividend yield
Proceeds from repurchase of equity
(25,000)
499,000
58,000
BB yield
Debt
Debt current
17,000
121,000
21,000
Long-term debt
619,000
592,000
658,000
Deferred revenue
44,000
49,000
Other long-term liabilities
113,000
123,000
142,000
Net debt
6,000
(14,000)
519,000
Cash flow
Cash from operating activities
208,000
118,000
137,000
CAPEX
(101,000)
(78,000)
(148,000)
Cash from investing activities
(20,000)
783,000
(147,000)
Cash from financing activities
(215,000)
(598,000)
(247,000)
FCF
347,000
1,596,000
(214,000)
Balance
Cash
437,000
475,000
110,000
Long term investments
193,000
252,000
50,000
Excess cash
547,650
639,450
91,250
Stockholders' equity
831,000
782,000
1,213,000
Invested Capital
1,393,350
1,324,550
2,326,750
ROIC
29.73%
23.28%
13.31%
ROCE
23.01%
22.57%
12.07%
EV
Common stock shares outstanding
404,200
411,400
403,200
Price
Market cap
EV
EBITDA
545,000
545,000
378,000
EV/EBITDA
Interest
25,000
29,000
23,000
Interest/NOPBT
5.54%
6.44%
7.72%